SCHEMBL7093351

SCHEMBL7093351

Cn1cc(-c2ccnc(N)n2)cc1C(=O)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JMJD6 Q6NYC1 1/20 0.46
CDC7 O00311 9/20 0.44
ADORA2A P29274 2/20 0.43
AURKA O14965 1/20 0.43
HSP90AA1 P07900 1/20 0.43
PRKACA P17612 1/20 0.43
JAK2 O60674 3/20 0.42
ROCK2 O75116 1/20 0.40
DBF4 Q9UBU7 1/20 0.40
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5397043 0.86 CDC7 (0.43) JMJD6CDC7ADORA2AAURKAHSP90AA1
SCHEMBL7089643 0.81 MAPT (0.52) ADORA2AMAPT
SCHEMBL6779517 0.76 TDP1 (0.49) JMJD6ADORA2ARAB9ANPC1ALDH1A1
SCHEMBL7092132 0.76 ADORA1 (0.56) JMJD6ADORA2AMAPT
SCHEMBL24414105 0.72 TDP1 (0.50) ADORA2ARAB9AALDH1A1L3MBTL1KDM4E
SCHEMBL29020234 0.71 TDP1 (0.49) JMJD6RAB9ANPC1ALDH1A1L3MBTL1
SCHEMBL26241207 0.70 TDP1 (0.51) JMJD6RAB9ANPC1ALDH1A1SMN1; SMN2
SCHEMBL31500310 0.70 CFD (0.44) SMN1; SMN2L3MBTL1
SCHEMBL30805989 0.70 CFD (0.44) SMN1; SMN2L3MBTL1
Hydrochloric Acid SCHEMBL31500289 0.69 CFD (0.43) SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363906-A2 HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-11-26 EP disclosed
WO-2002064586-A2 HETEROCYCLIC INHIBITORS OF ERK2 AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-08-22 WO disclosed